The regulatory recommendations for genotyping for HLA-B*15:02 as “standard-of-care” coupled with government subsidy of 75% for the test has contributed to a reduction in the number of CBZ- and phenytoin-associated SJS/TEN cases in Singapore. Here, HLA-B is linked to toxic epidermal necrolysis.